Brief: Aptose Biosciences Posts Q4 Loss Per Share of C$0.17
March 12 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND YEAR
ENDED
DECEMBER 31, 2018
* Q4 LOSS PER SHARE C$0.17
* TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF
DECEMBER
31, 2018 WERE $15.7 MILLION
Source text for Eikon: ID:nGNX8qYTtX
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting